STRUCTURAL BIOLOGY RESEARCH INFRASTRUCTURES FOR TRANSLATIONAL RESEARCH AND DISCOVERY
The iNEXT-Discovery partnership, a renewed team from the one that conceived, organised and successfully run the iNEXT consortium, brings together structural biology facilities for X-rays, NMR, cryo-EM and macromolecular biophysics, and aims to make them accessible to new user communities, to develop the methods further through joined research efforts, and to offer better integration between scientific fields and within the field of structural biology through scientific meetings, practical courses, and training workshops.
A major aim of iNEXT-Discovery is providing access to users from the European Union and all associated countries, to all participating facilities. Importantly, we aim to not only make available our state of the art instruments, but also make available to all users expert support, to help non-experts answer exciting scientific questions.
While our main focus is translational research in life sciences, we are actively looking forward to engage with the food, biotechnology and biomaterials sectors.
Please contact us with any of your questions.
COORDINATION AND MANAGEMENT
The project coordinator and the project manager are responsible for the smooth running for all operations related to iNEXT-Discovery. The project is continuously monitored by the Executive Board that makes decisions for all trivial matters that ensure smooth running of the project. The Management Board is monitoring progress and providing feedback for corrective actions and suggestions to the Executive Board. The General Assembly, which includes all partners, is the ultimate decision-making body of the consortium.
Coordinator |
Project Manager |
 |
 |
| Anastassis Perrakis, NKI | Hans Wienk, NKI |
Executive Board |
|||
 |
 |
 |
 |
| Susan Daenke, INSTRUCT | Eva Pereiro, ALBA | Harald Schwalbe, BMRZ | Manfred Weiss, HZB |
Management Board |
||
|
Lucia Banci, CIRMMP (Chair) |
|
|
PARTNERS
- NKI - The Netherlands Cancer Institute
- CEITEC - Masaryk University
- EMBL - European Molecular Biology Laboratory
- EMBL-GR - EMBL Grenoble
- EMBL-HH - EMBL Hamburg
- EMBL-HD - EMBL Heidelberg
- EMBL-EBI - EMBL European Bioinformatics Institute Hinxton
- EMBL-EuBI - EuroBioImaging ERIC
- INSTRUCT - INSTRUC-ERIC
- CSIC - Spanish National Research Council
- NeCEN - Leiden University
- ABSL - University of Leeds
- HZB - Helmholtz Zentrum Berlin
- MAX IV - Lund University
- UU - Utrecht University
- BMRZ - Goethe University Frankfurt
- SOLEIL - Synchrotron Soleil
- RALF-NMR - CNRS
- CIRMMP - Consorzio Interuniversitario Risonanze Magnetiche di Metallo Proteine
- ALBA - Synchrotron ALBA
- DIAMOND - Diamond Light Source
- CBI - Centre Europeen de Reserche en Biologie et Medecine
- NHRF - National Hellenic Research Foundation
- ITQB - Universidade Nova de Lisboa
- METROFOOD - ENEA / METROFOOD-RI ESFRI
- AU - Aarhus University
- IIMCB - International Insitute of Molecular and Cell Biology
- ELTE - Eötvös Loránd University
- EU-OS - EU-OPENSCREEN ERIC
- VU - University of Vilnius
- EATRIS - EATRIS-ERIC
SCIENTIFIC ADVISORY BOARD
iNEXT-Discovery’s international Scientific Advisory Board is composed of high-profile structural biologists with different scientific background and expertise. The members are:
 |
 |
 |
 |
 |
| Elspeth Garman (chair) | Rolf Boelens | Ilaria Ferlenghi | Kevin Gardner | Helen Saibil |
Elspeth Garman (Chair)
Professor of Methods development for stuctural biology, Department of Biochemistry, University of Oxford - Oxford, United Kingdom
Rolf Boelens
Professor of NMR Spectroscopy, Utrecht University; Coordinator H2020-project iNEXT - Utrecht, The Netherlands
Ilaria Ferlenghi
Head of Structural Microscopy at GSK Vaccines - Siena, Italy
Kevin Gardner
Director, Structural Biology Initiative, CUNY Advanced Science Research Center; Professor of Chemistry & Biochemistry, City College of New York - New York, United States
Helen Saibil
Professor of Structural Biology, Birkbeck College - London, United Kingdom